Studies have concluded that in critically ill COVID-19 patients, CRP and PCT have shown rebound increases upon cessation of immunomodulator treatment, and as such, clinicians should assess basic clinical infection signs and cultures for diagnosis of secondary bacterial infections.3,75. Here, CRP is linked to bacterial infectious disease.